On October 21, 2026, Judge Patti B. Saris of the District of Massachusetts granted in part and denied in part a medical device company’s (“Defendant”) motion for summary judgment in […]
On October 22, 2026, the Department of Justice (“DOJ”) Civil Division and the Department of Health and Human Services (“HHS”) announced a six-month Healthcare False Claims Act Self-Disclosure Pilot Program […]
On October 15, 2026, the Department of Justice’s National Fraud Enforcement Division (“NFED”) and the Department of Health and Human Services Office of Inspector General (“HHS-OIG”) announced a joint policy […]
The District of Massachusetts recently granted summary judgment to Janssen Biotech, Inc. (“Janssen”) in a declined False Claims Act qui tam. The relator alleged that Janssen gave physician practices free […]
In a significant decision for policyholders facing False Claims Act (“FCA”) claims, the Eastern District of Virginia granted judgment on the pleadings to a government contractor against its professional liability […]
On September 30, 2026, the Department of Justice announced a $22.5 million settlement with a Medicare Advantage (“MA”) plan to resolve allegations that it violated the False Claims Act by […]
On September 23, 2026, Jeanine Pirro, the U.S. Attorney for the District of Columbia, announced the creation of a new Fraud and Asset Recovery Division. The new Division will be […]
In a move with substantial implications for federal enforcement generally and the False Claims Act (“FCA”) in particular, the U.S. Department of Justice (“the Department”) on September 18, 2026 announced […]
Earlier this week, the Department of Justice (“DOJ”) announced a $25 million settlement with three Accenture entities to resolve allegations that they violated the FCA by engaging in conduct DOJ […]
In a landmark decision in Zafirov, the Eleventh Circuit yesterday rejected the argument that the FCA’s qui tam mechanism violates the Constitution’s Appointments Clause. Encouraged by concurring and dissenting opinions […]